Pfizer has entered a $43 billion merger agreement with biotechnology firm Seagen. The deal is designed to bolster the pharmaceutical giant's efforts to fight cancer by scaling up the production of a promising antibody drug.
“Pfizer is deploying its financial resources to advance the battle against cancer, a leading cause of death worldwide with a significant impact on public health,” said CEO Dr. Albert Bourla.
“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and expertise."
ADCs are designed to kill cancer cells and limit off-target toxicities. Bourla noted that oncology is the "largest growth driver in global medicine," and that the deal would improve Pfzier's position in the space.
Seagen forecast $2.2 billion in revenue in 2023, up 12 percent from last year. Pfizer said the company could contribute $10 billion in risk-adjusted revenues by 2030. This would supplement the company's existing oncology division, which brought in $12 billion in revenue in 2022 with a combination of prostate cancer and the breast cancer treatments.
“Pfizer shares our steadfast commitment to patients, and this combination is a testament to the passion, dedication and talent of the Seagen team to achieve our mission to discover, develop, and commercialize transformative cancer medicines that make a meaningful difference in people’s lives,” said Seagan CEO David Epstein.
The holiday season is underway and it's a good time to put your Christmas tree up if you haven't already. But making your home festive can be costly. Cameron Forbes, founder of Forbes Functions, joined Cheddar News to provide tips for decorating on a dime.
Google is moving forward with its previously-announced plan to delete inactive accounts and all associated data.
Federal regulators are investigating Chevrolet Volt hybrid cars after some drivers reported issues including sudden power loss and failure to restart.
Fed Chair Jerome Powell weighed in on interest rates, some of Tesla's cybertrucks have been delivered, Apple and Paramount have reportedly discussed bundling their streaming services together and Panera Bread has reportedly filed to go public.
Accounting firm PWC is facing a $7 million fine from U.S. regulators.
Build-A-Bear Workshop has been one of the most recognizable and beloved toy brands in the world since opening in 1997. Sharon Price John, CEO of Build-A-Bear Workshop, spoke with Cheddar News about its plans for the holiday season this year as well as the company's first animated feature film.
Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Stocks were generally flat after the opening bell on Friday ahead of Federal Reserve Chair Jerome Powell's comments in a speech at Spelman College later. Investors are growing optimistic that the central bank is done raising rates and may start cutting next year.
Holiday shopping on a budget.
The network of nearly 4,800 fake accounts was attempting to build an audience when it was identified and eliminated by the tech company, which owns Facebook and Instagram.
